Potential of mezlocillin as empiric single-agent therapy in febrile granulocytopenic cancer patients.

Mezlocillin was used as an initial empiric antibiotic therapy for febrile (> 101 degrees F, ca. 38.33 degrees C) granulocytopenic (< 1,000/microliter) cancer patients. Patients known to be colonized with an organism resistant to 100 micrograms of mezlocillin per mol were excluded. The initial...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Wade, J C, Schimpff, S C, Newman, K A, Fortner, C L, Moody, M R, Young, V M, Wiernik, P H
Format: Artigo
Idioma:Inglês
Publicat: 1980
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC283987/
https://ncbi.nlm.nih.gov/pubmed/6449902
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars